Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cannabidiol for Paramedian Forehead Flap Scar Healing
NCT05650697Phase 1Not yet recruiting
- Sponsor
- University of Oklahoma
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Zygel in scar (2 arms), sponsored by University of Oklahoma. Primary endpoint: Assessment of subjective and objective effects of CBD on the outcomes of healing scars at 2 years. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Zygel
03
Conditions
scar
Beyond the preview
Go deeper on NCT05650697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05650697.